Emily C Gathright1, Wen-Chih Wu2, Lori A J Scott-Sheldon3. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, CORO Building, Suite 309, 164 Summit Avenue, Providence, RI 02906, United States; Department of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, RI, United States. Electronic address: emily_gaithright@brown.edu. 2. Center forCardiac Fitness, The Miriam Hospital, Providence, RI, United States; Department of Medicine, Alpert School of Medicine, Brown University, Providence, RI, United States; Veterans Affairs Hospital, Providence, RI, United States. 3. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, CORO Building, Suite 309, 164 Summit Avenue, Providence, RI 02906, United States; Department of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, RI, United States; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, United States.
Abstract
BACKGROUND: Smoking cessation is recommended for adults with heart failure (HF). The prevalence of e-cigarette use among adults with HF is unknown. OBJECTIVE: To determine prevalence of and reasons for e-cigarette use among adults with HF. METHODS: Data from the Population Assessment of Tobacco and Health Study (Wave 1) were examined. RESULTS: Of 484 respondents with HF, 1% (weighted) reported current e-cigarette use, and 5% (weighted) reported dual cigarette/e-cigarette use. Adults with HF had higher odds of dual use (OR = 1.76, 95% CI: 1.22-2.54) compared to those without HF, controlling for age, sex, race, and income. Dual users with HF reported using e-cigarettes because they may be less harmful to nearby people and to themselves than cigarettes. CONCLUSIONS: E-cigarette use should be assessed and monitored to understand the safety and potential efficacy of e-cigarettes as a harm reduction approach for HF patients.
BACKGROUND: Smoking cessation is recommended for adults with heart failure (HF). The prevalence of e-cigarette use among adults with HF is unknown. OBJECTIVE: To determine prevalence of and reasons for e-cigarette use among adults with HF. METHODS: Data from the Population Assessment of Tobacco and Health Study (Wave 1) were examined. RESULTS: Of 484 respondents with HF, 1% (weighted) reported current e-cigarette use, and 5% (weighted) reported dual cigarette/e-cigarette use. Adults with HF had higher odds of dual use (OR = 1.76, 95% CI: 1.22-2.54) compared to those without HF, controlling for age, sex, race, and income. Dual users with HF reported using e-cigarettes because they may be less harmful to nearby people and to themselves than cigarettes. CONCLUSIONS: E-cigarette use should be assessed and monitored to understand the safety and potential efficacy of e-cigarettes as a harm reduction approach for HFpatients.
Authors: Montse Ballbè; Jose M Martínez-Sánchez; Xisca Sureda; Marcela Fu; Raúl Pérez-Ortuño; José A Pascual; Esteve Saltó; Esteve Fernández Journal: Environ Res Date: 2014-09-27 Impact factor: 6.498
Authors: Amil M Shah; Marc A Pfeffer; L Howard Hartley; Lemuel A Moyé; Bernard J Gersh; John D Rutherford; Gervasio A Lamas; Jean L Rouleau; Eugene Braunwald; Scott D Solomon Journal: Am J Cardiol Date: 2010-08-11 Impact factor: 2.778
Authors: Andrew M Busch; Eleanor L Leavens; Theodore L Wagener; Maria L Buckley; Erin M Tooley Journal: J Cardiopulm Rehabil Prev Date: 2016 Sep-Oct Impact factor: 2.081
Authors: Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton Journal: Tob Control Date: 2016-08-08 Impact factor: 7.552
Authors: Diann E Gaalema; Irene Pericot-Valverde; Janice Y Bunn; Andrea C Villanti; Antonio Cepeda-Benito; Nathan J Doogan; Diana R Keith; Allison N Kurti; Alexa A Lopez; Tyler Nighbor; Maria A Parker; Amanda J Quisenberry; Ryan Redner; Megan E Roberts; Cassandra A Stanton; Philip A Ades; Stephen T Higgins Journal: Prev Med Date: 2018-05-08 Impact factor: 4.018
Authors: Sarah C Snow; Gregg C Fonarow; Joseph A Ladapo; Donna L Washington; Katherine J Hoggatt; Boback Ziaeian Journal: Am J Med Date: 2018-12-16 Impact factor: 4.965
Authors: Andrew Stokes; Jason M Collins; Kaitlyn M Berry; Lindsay M Reynolds; Jessica L Fetterman; Carlos J Rodriguez; Michael B Siegel; Emelia J Benjamin Journal: J Am Heart Assoc Date: 2018-04-26 Impact factor: 5.501